News

Filter

Current filters:

Inspra

1 to 9 of 29 results

Heart meeting hears disappointing results for J&J/Scios Natrecor; strong findings for Pfizer’s Inspra

15-11-2010

Studies presented at the American Heart Association conference taking place in Chicago, showed that people…

Cardio-vascularInspraJohnson & JohnsonNatrecorPfizerPharmaceuticalResearchScios

Pfizer halts cardiovascular drug Inspra trial recruitment on positive results

28-05-2010

US global drugs behemoth Pfizer says that it plans to halt recruitment to the EMPHASIS-HF trial, assessing…

Cardio-vascularInspraPfizerPharmaceuticalResearch

Nine NCEs added to Japan's NHI drug list

08-10-2007

Among nine New Chemical Entities comprising14 products added to Japan's National Health Insurance drug…

AldaraEplerenoneImiquimodInspraKyowa HakkoMochida PharmaceuticalOrganonPfizerTopamaxtopiramate

Japanese regulator gives nod to three new drugs

21-05-2007

Japan's First Committee on Drugs of the Council on Pharmaceuticals and Food Sanitation has recommended…

EplerenoneInspraJohnson & JohnsonOrganonPfizerRocuronium Bromide InjectionTopamaxtopiramateZemuron

Australia OKs Inspra

19-12-2005

Pfizer's Inspra (eplerenone) is to be added to Australia's Pharmaceutical Benefits Scheme from February…

EplerenoneInspraPfizer

Early use of Pfizer's Inspra reduces early cardiac death risk

22-08-2005

According to data published in the August edition of the Journal of the American College of Cardiology,…

EplerenoneInspraPfizer

1 to 9 of 29 results

COMPANY SPOTLIGHT

Menarini

Back to top